Exocytosis of neutrophil formyl Peptide Receptor-Like 1 (fPRL1) results in downregulation of cytoplasmic fPRL1 in patients with purulent dermatitis

Clinical and Vaccine Immunology

Volumn 14, Issue 6, 2007, Pages 678-684

  Ohara, Eiji ^a   Kumon, Yoshitaka ^a   Kobayashi, Toshihiro ^a   Takeuchi, Hiroaki ^a   Sugiura, Tetsuro ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASMIC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR LIKE 1;

ADULT; AGED; ARTICLE; CASE REPORT; CELL MEMBRANE; CHEMOTAXIS; DERMATITIS; DOWN REGULATION; EXOCYTOSIS; FEMALE; FOURNIER GANGRENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MALE; MORPHOLOGY; NECROTIZING FASCIITIS; NEUTROPHIL; NEUTROPHIL GRANULE; PRIORITY JOURNAL; PURULENT DERMATITIS; REGULATORY MECHANISM; STAINING; STIMULATION;

AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOPLASM; DOWN-REGULATION; EXOCYTOSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUTROPHILS; PYODERMA; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 34547097758     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00426-06     Document Type: Article

References (29)

1. Almkvist, A., J. Fäldt, C. Dahlgren, H. Leffler, and A. Karlsson. 2001. Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect. Immun. 69:832-837.
2. Badolato, R., J. A. Johnston, J. M. Wang, D. McVicar, L. L. Xu, J. J. Oppenheim, and D. J. Kelvin. 1995. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155:4004-4010.
3. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180:203-209.
4. Bao, L., N. P. Gerard, R. L. Eddy, T. B. Shows, and C. Gerard. 1992. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13:437.
5. Barkia, A., C. Martin, P. Puchois, J. C. Gesquiere, C. Cachera, A. Tartar, and J. C. Fruchart. 1988. Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide. J. Lipid Res. 29:77-84.
6. Bylund, J., A. Karlsson, F. Boulay, and C. Dahlgren. 2002. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70:2908-2914.
7. Bylund, J., M. Samuelsson, L. V. Collins, and A. Karlsson. 2003. NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Exp. Cell Res. 282:70-77.
8. Faurschou, M., and N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5:1317-1327.
9. Fiore, S., and C. N. Serhan. 1995. Lipoxin A4 receptor activation is distinct from that of formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34: 16678-16686.
10. Gatt, M. E., S. Urieli-Shoval, L. Preciado-Patt, M. Fridkin, S. Calco, Y. Azar, and Y. Matzner. 1998. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. J. Lab. Clin. Med. 132:414-420.
11. Kobayashi, T., and J. M. Robinson. 1991. A novel intracellular compartment with unusual secretary properties in human neutrophil. J. Cell Biol. 113:743-756.
12. Kumon, V., T. Hosokawa, T. Suehiro, Y. Ikeda, J. D. Sipe, and K. Hashimoto. 2002. Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells. Amyloid 9:237-241.
13. Kumon, Y., T. Suehiro, D. J. Faulkes, T. Hosakawa, Y. Ikeda, P. Woo, J. D. Sipe, and K. Hashimoto. 2002. Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/ enhancer binding proteins (C/EBP) and is distinct from HepG2 cells. Scand. J. Immunol. 56:504-511.
14. Kumon, Y., T. Suehiro, T. Hosokawa, Y. Ikeda, J. D. Sipe, and K. Hashimoto. 2001. Acute-serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells, p. 96-98. In M. Bely and A. Apathy (ed.), Amyloid and amyloidosis. PXP Elso Magyar Digit-lis Nyomda Rt., Budapest, Hungary.
15. Kumon, V., K. Arii, T. Suehiro, Y. Ikeda, H. Enzan, and K. Hashimoto. 2005. Acute-phase serum amyloid A (A-SAA) synthesized by human synovial cell (SC) induces SC migration, p. 212-214. In G. Grateau, K. Robert, and M. Skinner (ed.), Amyloid and amyloidosis. CRC Press, Boca Raton, FL.
16. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12:91-105.
17. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23:541-548.
18. Le, Y., Y. Zhou, H. Tao, and J. M. Wang. 2004. Formylpeptide receptors and their potential roles in inflammatory airway diseases. Clin. Exp. Allergy Rev. 4:155-161.
19. Linke, R. P., V. Bock, G. Valet, and G. Rothe. 1991. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem. Biophys. Res. Commun. 176:1100-1105.
20. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptor. Annu. Rev. Immunol. 12:593-633.
21. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267:7637-7643.
22. Renshaw, S. A., S. J. Timmons, V. Eaton, L. R. Usher, M. Akil, C. D. Bingle, and M. K. Whyte. 2000. Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. J. Leukoc. Biol. 67:662-668.
23. Selvatici, R., S. Falzarano, A. Mollica, and S. Spisani. 2006. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 534:1-11.
24. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane G protein coupled recepter, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395-402.
25. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for antiinflammatory receptors. J. Exp. Med. 185:1693-1704.
26. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265:501-523.
27. Urieli-Shoval, S., P. Cohen, S. Eisenberg, and Y. Matzner. 1998. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem. 46:1377-1384.
28. Urieli-Shoval, S., R. L. Meek, R. H. Hanson, N. Eriksen, and E. P. Benditt. 1994. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am. J. Pathol. 145:650-660.
29. Whyte, M., S. Renshaw, R. Lawson, and C. Bingle. 1999. Apoptosis and the regulation of neutrophil life span. Biochem. Soc. Trans. 27:802-807.